Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Alliqua BioMedical, Inc. (ADYX) had Normalized Pre-Tax Income of $-1.90M for the most recently reported fiscal quarter, ending 2019-09-30.
| Income Statement Financials | |
-- |
|
$-1.90M |
|
-- |
|
-- |
|
$1.67M |
|
$-1.67M |
|
$-0.22M |
|
$-1.90M |
|
|
Normalized Pre-Tax Income |
$-1.90M |
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.67M |
|
$-1.44M |
|
5.81M |
|
5.81M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$2.54M |
|
$0.01M |
|
$0.71M |
|
$3.25M |
|
$13.80M |
|
-- |
|
$0.52M |
|
$14.32M |
|
$-11.06M |
|
$-11.06M |
|
$-11.06M |
|
5.81M |
|
| Cash Flow Statement Financials | |
$-4.77M |
|
-- |
|
$3.41M |
|
$1.94M |
|
$0.58M |
|
$-1.36M |
|
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.18 |
|
-- |
|
-- |
|
-- |
|
-0.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
17.13% |
|
17.13% |
|
-58.24% |
|
17.13% |
|
$-1.90 |
|
$-0.82 |
|
$-0.82 |
|